View EO 12866 Meeting 0938-AT73

  Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals; the Long-Term Care Hospital Prospective Payment System; and FY 2020 Rates (CMS-1716-F)

  0938-HHS/CMS

  Proposed Rule Stage

  02/21/2019 01:00 PM

  Gilead, Johnson & Johnson, Alliance for Regenerative Medicine, BIO, Novartis, The Moran Company


 
List of Documents
ARM/BIO Meeting: Medicare Reimbursement for CAR T-Cell Therapy
 
List of Attendees Participation
•   Aaron Fischbach  - HHS/IOS In Person 
•   Cara Kelly  - NONE In Person 
•   Steve Phillips  - Johnson & Johnson In Person 
•   Kevin Kirby  - The Moran Company In Person 
•   Arielle Gurwitch  - BIO In Person 
•   Greg   - Johnson & Johnson In Person 
•   Vadim Lubarzky  - Novartis In Person 
•   Julie Wise  - OMB/OIRA In Person 
•   Jenna Waltersdorf  - Gilead In Person 
•   Melissa Medeiros  - OMB/HD In Person 
•   Robert Falb  - Alliance for Regenerative Medicine In Person 
•   Mallory O'Connor  - BIO In Person